Intellipharmaceutics International Inc. (Nasdaq: IPCI), and Par Pharmaceutical, Inc. (NYSE: PRX) have added the development and commercialization of additional strengths ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE